SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced that the Company will provide a corporate overview at Biotech Showcase 2023 taking place in San Francisco, California, from January 9-11, 2023.
Presenter Hugo Peris, Chief Executive Officer and President of Spiral will be available for one-on-one meetings throughout the conference. Conference attendees should schedule meetings on the Biotech Showcase website.
Date: Tuesday, January 10, 2023
Time: 2:30 pm PT
Location: Franciscan-B, Ballroom Level, Hilton San Francisco Union Square
About Spiral Therapeutics
Spiral Therapeutics is a clinical-stage company delivering therapies for inner ear disorders. Spiral’s novel drug delivery platform allows for minimally invasive, precise and durable exposure of drugs to the cochlea. Spiral is advancing a therapeutic pipeline with focus on balance disorders and hearing loss. Spiral’s lead program, SPT-2101, is a sustained-release steroid formulation for the treatment of Meniere’s Disease. For more information, visit: www.spiraltx.com